Live PPR

Indications

• Clinical term 1
• Common term 1
• Clinical term 2
• Common term 2

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Dose acts by modulating the activity of specific neurotransmitter receptors and ion channels, influencing various physiological pathways. Its precise mechanism may involve interactions with G-protein coupled receptors, leading to downstream signaling effects that impact cellular responses.

Pharmacodynamics

Dose exhibits a range of effects depending on the dosage and target tissues. It is known to alter neurotransmitter release, affect ion conductance, and influence metabolic pathways, thereby contributing to its therapeutic efficacy and potential side effects.

Pharmacokinetics

Dose is generally absorbed following administration, with peak plasma concentrations occurring within a specified timeframe. Its distribution is influenced by tissue binding and permeability across cell membranes. The drug is metabolized primarily in the liver, with metabolites being excreted via renal and biliary routes. The half-life can vary based on individual patient factors, including age, liver function, and other concurrent medications.

Dosage

Children: Refer to established medical guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established medical guidelines or consult a healthcare professional for appropriate dosing.

Pregnancy

The safety of this drug during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

There is limited information on the excretion of this drug in human milk. Use with caution during breastfeeding.

Storage

Store in a cool, dry place, away from direct light. Keep out of reach of children.

Indications

• Prevention of peste des petits ruminants in small ruminants
• Supportive care for infected sheep and goats

Dosage

Children: Refer to veterinary guidelines for specific dosing of vaccines and supportive treatments in young animals.

Adults: Refer to veterinary guidelines for specific dosing of vaccines and supportive treatments.

Mechanism of action

PPRV infects host cells by binding to the signaling lymphocyte activation molecule (SLAM) receptor on the surface of lymphocytes and other immune cells. This enables the virus to enter the cells and replicate, leading to cell death and impairment of the immune response. The resulting immune dysfunction contributes to the clinical manifestations of the disease.

Pharmacodynamics

The clinical signs of PPR are a result of the virus's impact on the immune system and respiratory tract. The disease leads to severe immunosuppression, making animals susceptible to secondary infections. Additionally, the destruction of epithelial cells in the respiratory and gastrointestinal tracts contributes to the symptoms observed during infection.

Pharmacokinetics

The pharmacokinetics of antiviral agents used in the management of PPR are not well defined due to the focus on vaccination and supportive care. Antiviral treatments, when used, would typically be administered based on the specific pharmacological properties of the agents chosen and the clinical condition of the affected animal.

Pregnancy

Limited data is available on the use of peste during pregnancy. Caution is advised.

Breast-feeding

Limited data is available on the excretion of peste in breast milk. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight. Ensure that the product is tightly closed.

Indications

• Petit mal seizures
• Absence seizures
• Generalized epilepsy

Dosage

Children: Refer to the BNF for Children for specific dosing information as it is dependent on the specific medication and the child's age and weight.

Adults: Refer to specific guidelines or the BNF for appropriate dosing information as it can vary based on the medication used.

Mechanism of action

The precise mechanism of action for the treatment of petit mal seizures typically involves modulation of neurotransmitter activity, particularly the enhancement of GABAergic transmission. This increases inhibitory neurotransmission in the brain, thereby stabilizing neuronal excitability and reducing the likelihood of seizure occurrence. Some antiepileptic drugs employed for this purpose may also affect sodium and calcium channels, further contributing to their anticonvulsant effects.

Pharmacodynamics

Pharmacodynamically, drugs used to treat petit mal seizures work by increasing the threshold for neuronal firing, thereby reducing the excitability of neurons. This helps to prevent the synchronous neuronal discharges that characterize seizures. The effectiveness of these medications can vary based on individual patient response, and they may also have sedative effects, which should be monitored.

Pharmacokinetics

The pharmacokinetics of antiepileptic drugs can vary widely. Generally, these medications are well-absorbed from the gastrointestinal tract and exhibit a range of half-lives. Metabolism often occurs in the liver, with some drugs undergoing extensive first-pass metabolism. Excretion typically happens through the kidneys, and dose adjustments may be necessary in patients with renal impairment. Monitoring plasma levels may be required for certain medications to ensure therapeutic efficacy while minimizing toxicity.

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and if the benefits outweigh the risks.

Breast-feeding

Caution is advised as it is not known if the drug is excreted in human milk.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Bovine respiratory disease
• Mastitis
• Metritis
• Bloat
• Coccidiosis
• Parasitic infections
• Nutritional deficiencies

Dosage

Children: Dosage for juvenile ruminants also varies based on the specific drug and condition. It is recommended to consult veterinary guidelines for appropriate dosing in young animals.

Adults: Dosage for adult ruminants varies widely based on the specific drug, condition being treated, and species. Refer to veterinary pharmacology resources for specific dosing information.

Mechanism of action

Ruminants digest food through a process called rumination, which involves regurgitating food, chewing it, and then swallowing it again. The rumen chamber houses a diverse population of bacteria, protozoa, and fungi that ferment ingested plant material, breaking down cellulose into simpler sugars and fatty acids. This microbial fermentation is crucial for the digestion of fibrous foods.

Pharmacodynamics

In ruminants, pharmacodynamics can vary significantly based on the unique physiology and microbiome of the animal. Drugs administered to ruminants may require careful consideration of their absorption and metabolism due to the extensive fermentation process in the rumen. The interaction between a drug and the ruminant's microbiota can influence the drug's efficacy and safety.

Pharmacokinetics

The pharmacokinetics of drugs in ruminants can be complex due to their unique digestive physiology. After administration, drugs may undergo significant alterations due to rumen fermentation, which can affect absorption, distribution, metabolism, and excretion. For example, some drugs may be degraded by ruminal microorganisms before they can exert their therapeutic effect, while others may be absorbed more slowly due to the presence of fibrous feed.

Indications

• Bacterial infections
• Viral infections
• Epidemiological studies
• Antibiotic resistance monitoring

Dosage

Children: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Adults: Refer to specific antimicrobial treatment guidelines based on the strain identified and the infection site.

Mechanism of action

The mechanism of action for a strain depends on the type of microorganism it represents. For pathogenic bacteria, the strain may produce toxins, evade the host's immune response, or possess resistance mechanisms that allow it to survive in the presence of antibiotics. For viruses, strains may exhibit mutations that alter their ability to infect host cells or evade antiviral therapies.

Pharmacodynamics

Pharmacodynamics in the context of strains involves the interaction between the strain and the host's immune system, as well as the effects of specific antimicrobial agents on the strain. These interactions can influence the efficacy of treatments and the development of resistance.

Pharmacokinetics

Pharmacokinetics is not directly applicable to strains themselves but rather to the drugs used to treat infections caused by specific strains. Factors such as absorption, distribution, metabolism, and excretion of antimicrobial agents can vary depending on the strain's characteristics and the site of infection.

Pregnancy

There is limited information on the safety of strain in pregnancy. It is advisable to consult healthcare professionals for guidance.

Breast-feeding

Safety during breastfeeding is not well established. It is recommended to seek medical advice before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Neoplastic diseases
• Certain types of cancer
• Chemotherapy regimens

Dosage

Children: Refer to the BNF for Children for precise paediatric dosing recommendations.

Adults: Refer to the BNF for specific dosing guidelines based on the clinical scenario.

Mechanism of action

Tcid acts by disrupting cellular processes, leading to cytotoxic effects in targeted cells. It may interfere with DNA synthesis or function through alkylation, which can result in apoptosis in rapidly dividing cells.

Pharmacodynamics

Tcid shows a dose-dependent relationship in its efficacy, affecting cell viability and metabolic processes. Its cytotoxic effects are more pronounced in neoplastic cells compared to normal cells, making it useful in oncology.

Pharmacokinetics

Tcid is absorbed through the gastrointestinal tract and undergoes hepatic metabolism. Its elimination half-life is variable, depending on individual patient factors, and it is primarily excreted through renal pathways.

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Use caution. Limited data available on excretion in breast milk.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Influenza
• HIV/AIDS
• Hepatitis B and C
• Herpes simplex virus infections
• Cytomegalovirus infections
• COVID-19
• Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.